GIST Improves Insomnia Symptoms with 'Transcranial Photobiomodulation' Technology
Promoting Mitochondrial Energy Metabolism with Near-Infrared Light
Significant Reduction in Pittsburgh Sleep Quality Index Observed in Trials
On September 23, the Gwangju Institute of Science and Technology (GIST) announced that the research team led by Professors Tae Kim and Jaegwan Kim from the Department of Biomedical Engineering has revealed the effects of 'transcranial photobiomodulation (tPBM)' technology—using near-infrared light on the head to assist sleep—on the brain's sleep regulation process and confirmed its potential to improve insomnia symptoms.
(From left) Dr. Jieun Jung, CSO of TeddyMedi Co., Ltd., Professor Tae Kim and Professor Jaegwan Kim from the Department of Biomedical Engineering at GIST. Provided by GIST
View original imageThe research team examined the influence of near-infrared light on the brain's sleep regulation using cells and mice, and also investigated its potential to improve sleep in adults with insomnia symptoms.
Insomnia is a common sleep issue experienced by many, typically treated with sleeping pills or cognitive behavioral therapy. However, concerns about dependency and side effects exist with long-term medication use, while cognitive behavioral therapy requires regular participation and may not always be accessible for everyone.
To explore new non-pharmacological sleep management methods that could supplement existing treatments, the research team focused on utilizing the brain’s natural sleep regulation process. The longer a person stays awake, the higher the 'sleep pressure' that builds up in the brain, driving the need to sleep. A central molecule in this process is adenosine. As a person remains awake, adenosine gradually accumulates in the brain, promoting drowsiness and sleep onset.
The team highlighted near-infrared light as a means to increase adenosine. 'Near-infrared light' is an invisible type of light that can partially penetrate the scalp and skull to reach brain tissue, and is known to affect the mitochondria—organelles responsible for energy production in brain cells. The researchers hypothesized that stimulating mitochondrial energy metabolism with near-infrared light would increase the production of adenosine triphosphate (ATP), the cell’s energy source, and that the subsequent breakdown of ATP would yield more adenosine, thereby elevating sleep pressure and facilitating sleep.
To confirm this, the researchers first shone near-infrared light on several types of brain cells and found that ATP levels increased. In a subsequent experiment with mice, near-infrared light exposure reduced the amount of time spent awake and increased non-rapid eye movement (NREM) sleep, encompassing both light and deep sleep stages. Notably, adenosine concentrations in the mouse brain increased, as did delta waves associated with deep sleep. These effects persisted for up to three hours after cessation of the stimulation.
Next, a preliminary clinical trial was conducted with 40 adults experiencing insomnia symptoms. Participants were randomly assigned to a 'stimulation group' that received near-infrared light or a 'control group' that wore the same device without actual near-infrared exposure. For one week, participants wore a headband equipped with near-infrared LEDs before bedtime each night. Both the researchers and participants were blinded as to who received actual stimulation. In the stimulation group, near-infrared light at a wavelength of 850 nanometers (nm) was applied for up to one hour, while in the control group, the device emitted no near-infrared light.
The Sleep Improvement Effects and Proposed Mechanism of Transcranial Photobiomodulation (tPBM). Provided by GIST
View original imageAs a result, participants in the stimulation group reported significant improvements in perceived insomnia symptoms and sleep quality. Specifically, scores on the 'Insomnia Severity Index (ISI),' which measures the severity of insomnia symptoms such as difficulty falling or staying asleep, decreased by 26%. The 'Pittsburgh Sleep Quality Index (PSQI),' which assesses overall sleep quality, decreased by 29.6%. For both indices, lower scores indicate alleviation of insomnia symptoms and improvement in sleep quality.
Notably, the stimulation group showed overall improvement in sleep status, including measurements related to time-to-sleep onset and reductions in nighttime discomfort. However, these results are based on subjective participant reports. No significant difference between the two groups was observed in objective sleep measures recorded with wrist-worn devices. Conversely, when analyzing only those participants who wore the device according to protocol, the time from device application to falling asleep decreased by approximately 30%. Since adenosine levels in the human brain were not directly measured, further studies are needed to determine whether the adenosine increase observed in animals similarly contributes to sleep improvement in humans.
Dr. Jeeun Jung (first author) at TeddyMedi Co. noted, "The significance of this study lies in examining the relationship between near-infrared stimulation and sleep through a stepwise approach, spanning cells, animals, and humans."
Professor Tae Kim (co-corresponding author) from the Department of Biomedical Engineering at GIST stated, "Through this preliminary clinical trial, we confirmed the potential for improvements in participant-perceived insomnia symptoms and sleep quality. We aim to verify objective sleep improvements and safety over long-term use in larger-scale participants and further develop non-pharmacological sleep management technologies."
Professor Jaegwan Kim (co-corresponding author) from the Department of Biomedical Engineering at GIST commented, "It will be necessary to closely investigate effects depending on wavelength, light intensity, stimulation time, and timing, and to specify appropriate photostimulation conditions. By integrating precise photostimulation with sleep measurement technologies, we expect to advance towards personalized technologies tailored to individual sleep states and biological rhythms."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
This research, led by Professors Tae Kim and Jaegwan Kim and conducted by Dr. Jeeun Jung, was supported by the Ministry of Health and Welfare's Electronic Medicine Technology Development Program, the Ministry of Health and Welfare's K-MediST Support Program, and the Ministry of Science and ICT's Brain Science Leading Convergence Technology Development Program. The results were published online in the international journal 'Molecular Psychiatry,' focusing on psychiatry on September 15, 2026, and introduced on the 'People Who Brighten Korea' section of the Biological Research Information Center (BRIC) on September 18.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.